In a recent study posted to the medRxiv preprint* server, researchers in the United States investigated the efficacy of a BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB1.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results